Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Tranexamic Acid in Reducing Myomectomy Associated Blood Loss in Federal Teaching Hospital Abakaliki.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* non-pregnant women with symptomatic myomas women with no known contraindication to tranexamic acid~Exclusion Criteria:~* past history of thromboembolic disorder, ischaemic heart disease, malignancy or liver disease

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- group A: Cases that had tranexamic acid infusion (Type: EXPERIMENTAL): Group A had perioperative tranexamic acid infusion at the rate of 100mls per hour
- Group B: Control (Type: PLACEBO_COMPARATOR): control were given perioperative placebo at the rate of 100mls per hour

Based on this trial design, predict the completion outcome and termination type (if applicable).